Managing Parkinson’s Disease: Treatment, Therapy, and Support Strategies

Parkinson’s disease has no cure yet, but that does not mean little can be done. Today, people living with Parkinson’s have access to a wide and growing range of management strategies – from medications and surgery to exercise, diet, psychological support, and social inclusion efforts. The goal is not just symptom control, but maintaining independence, dignity, and quality of life. Understanding how these strategies work, and why each one matters, is key for anyone supporting or living alongside someone with Parkinson’s.

Medical treatment: medications and surgery 🔗

Medical management remains the first line of treatment for Parkinson’s disease. Since the condition is caused by the loss of dopamine-producing neurons in the brain, most medications work by replenishing or mimicking dopamine. Levodopa (combined with carbidopa) – sold under brand names such as Sinemet – is the most commonly prescribed and most effective drug for managing motor symptoms like slowness of movement and muscle rigidity. Dopamine agonists such as pramipexole and ropinirole act similarly to dopamine in the brain and are often used as a first treatment, with levodopa added later if symptoms remain uncontrolled. MAO-B inhibitors, COMT inhibitors, and anticholinergic agents round out the pharmacological toolkit, each targeting different aspects of the dopamine pathway.

Beyond motor symptoms, Parkinson’s also produces a significant non-motor burden. Careful multidisciplinary management is required for the wide range of non-motor symptoms, which can have a major impact on quality of life. Antidepressants, for example, are commonly prescribed to address depression and anxiety that arise from changes in brain chemistry – not just as emotional reactions to the diagnosis.

When surgery becomes an option 🔗

Surgery is considered when medications no longer manage symptoms adequately, and it is typically reserved for patients who have already optimised their drug regimen. The most common surgical procedure today is deep brain stimulation (DBS), which is typically used for patients who no longer respond to medication predictably or who suffer medication-induced dyskinesia. Lesion surgery – where small, targeted lesions are made in specific movement-controlling parts of the brain – is another option. It is important to understand that surgery may help with the symptoms of Parkinson’s, but it does not cure the disease or stop its progression.

Deep brain stimulation: how it works 🔗

Deep brain stimulation (DBS) is one of the most significant therapeutic advances in Parkinson’s management. DBS is a surgical therapy that has been FDA-approved for over a decade and involves surgically implanting a small electrode into a specific region of the brain that governs movement. A pacemaker-like device – called a neurostimulator – is implanted in the chest wall and connected to the electrode via a wire under the skin. It delivers continuous electrical impulses that regulate abnormal brain activity responsible for tremor, stiffness, and involuntary movements.

Since DBS is reversible and adjustable, and has a more favourable safety profile, it has become the predominant surgical procedure for Parkinson’s disease over older procedures like pallidotomies and thalamotomies. Good candidates are generally those who respond well to levodopa but experience significant fluctuations in that response throughout the day. DBS may also be helpful when people experience dyskinesia – extra, uncontrolled movements that can occur as a side effect of long-term drug therapy. For those who are not surgical candidates, focused ultrasound offers a non-invasive alternative for motor symptoms that cannot be controlled with medication.

The role of exercise and physiotherapy 🔗

Exercise is no longer considered just a healthy lifestyle recommendation for people with Parkinson’s – it is now recognised as an essential part of treatment. Research shows that consistent exercise – at least 2.5 hours per week – can slow symptom progression and improve both physical and emotional wellbeing. The Parkinson’s Outcomes Project, one of the largest clinical studies of the disease, found that people who began exercising earlier in their disease course and sustained that habit experienced a slower decline in quality of life compared to those who started later.

Multiple forms of exercise have been found to have benefits in early and mid-stage disease across a range of motor and non-motor symptoms, and evidence from longitudinal studies confirms that disability is delayed when regular exercise is sustained over long periods. Aerobic activities, strength training, balance exercises, and flexibility work all contribute. There is also emerging evidence that exercise may be neuroprotective – that is, it may help slow the degeneration of dopamine-producing neurons themselves.

What physiotherapy specifically offers 🔗

In Parkinson’s management, physiotherapy addresses five core areas: physical fitness, transfers, manual activities, balance, and gait. A physiotherapist can design a personalised programme targeting the specific challenges a person faces at their particular stage of the disease. At Johns Hopkins Medicine, physical therapists work to increase mobility, strength and balance, and to help patients remain as independent as possible. Specialist approaches such as LSVT BIG training focus on increasing the amplitude of movement, which tends to decrease as Parkinson’s progresses. Group exercise settings offer the added benefit of social connection, which becomes increasingly valuable as the disease progresses and isolation becomes a risk.

Importance of a healthy diet 🔗

Nutrition is an often-underestimated dimension of Parkinson’s management. As the disease progresses, both motor and non-motor symptoms directly affect a person’s ability to eat well. Difficulty chewing, swallowing problems (dysphagia), constipation, reduced sense of smell, and cognitive changes all interfere with food intake. As the disease progresses, increasing severity of both motor and non-motor symptoms can significantly impact dietary choices and nutritional intake.

Studies show that targeted nutrition may slow Parkinson’s disease advancement, and a diet that includes a variety of whole grains, vegetables, fruits, and protein-rich foods can improve overall health. The Mediterranean diet, the DASH diet, and the MIND diet have all shown promise in research. Since no preventative or curative therapy for Parkinson’s currently exists, nutrition and diet represent modifiable risk factors for reducing disease burden. Poor nutritional status has been directly linked in clinical studies to worse motor function, greater cognitive impairment, higher levels of depression and anxiety, and lower overall quality of life.

Practical dietary considerations include staying well hydrated (six to eight glasses of water daily), eating fibre-rich foods to manage constipation, and being mindful of protein intake – since high-protein meals can interfere with levodopa absorption. People with significant swallowing difficulties may benefit from softer-textured foods or consultation with a speech-language therapist and dietitian.

Creating an accessible environment 🔗

As Parkinson’s affects mobility and fine motor control, the physical environment plays a major role in a person’s safety and independence. Simple home modifications can make a significant difference. Installing ramps in place of steps, fitting handrails along corridors, bathrooms, and staircases, using non-slip mats, and placing commonly used items within easy reach all reduce the risk of falls and make daily tasks more manageable.

Assistive devices are equally important. Shower chairs, grab bars, weighted cutlery, and button-hook tools help compensate for declining dexterity. For those whose handwriting has become difficult, switching to typing for communication preserves independence. Voice-activated technology can help manage phones, lights, and other household systems without requiring fine motor precision. Occupational therapists are trained to assess the individual’s home environment and daily routines, recommending targeted adaptations to preserve function for as long as possible. The aim is always to maintain participation in daily life with the least possible assistance.

Providing psychological support 🔗

Mental health is a core part of managing Parkinson’s disease, not a secondary concern. Depression affects up to 50% of people with Parkinson’s and may even be present before a formal diagnosis is made. Anxiety and depression co-occur frequently, and these disorders are more common in people with Parkinson’s than in similarly disabling conditions like diabetes or rheumatoid arthritis – pointing to the fact that these are neurological features of the disease, not simply reactions to it.

According to the Parkinson’s Foundation’s Parkinson’s Outcomes Project, depression and anxiety are the number one factors affecting overall health for people living with Parkinson’s disease. Antidepressants – particularly SSRIs – are effective for managing these conditions. Cognitive behavioural therapy (CBT) has demonstrated efficacy for both depression and anxiety. Research from UCLA Health shows that loneliness and social isolation are major risk factors for deteriorating health among people with Parkinson’s, making social support a central component of psychological treatment, not just an add-on.

Family members and caregivers play an indispensable role here. Actively listening, acknowledging emotional experiences, and connecting the person with professional mental health support all contribute meaningfully. Peer support groups – where people with Parkinson’s share experiences and strategies – have shown positive outcomes in reducing isolation and improving mental wellbeing.

Reducing social barriers for inclusion 🔗

Stigma significantly impacts individuals with Parkinson’s disease and their caregivers, exacerbating social isolation, psychological distress, and reducing quality of life. Visible symptoms like tremor or an expressionless face are frequently misread by the public – a tremor may be mistaken for intoxication, while reduced facial expression can be perceived as unfriendliness or disinterest. Such public and self-misjudgments can lead to social withdrawal, anxiety, isolation, reluctance to seek health care, and depression.

These misunderstandings can push people with Parkinson’s to avoid social situations entirely, deepening isolation and worsening both physical and mental health outcomes. Research indicates that stigma in Parkinson’s can aggravate poverty through loss of income and increase the severity of disability. Breaking this cycle requires deliberate societal sensitisation – public education campaigns, workplace inclusion policies, and community programmes that normalise the presence of people with neurological conditions.

A practice called “social prescribing” – where doctors refer patients to community-based services such as support groups, yoga teachers, and mindfulness coaches – has shown good outcomes in the United Kingdom and represents a promising model for broader adoption. When communities adopt an informed, accepting attitude toward Parkinson’s, individuals with the condition are more likely to remain socially active, seek care earlier, and experience better overall wellbeing. Inclusion is not a soft goal – it is a measurable health outcome.

What do you think? Given how interconnected these management strategies are – from medication to mental health to social inclusion – do you think current healthcare systems do enough to address Parkinson’s as a whole-person condition, or are certain dimensions still being overlooked? And for those in teaching or caregiving roles, how might better public education about Parkinson’s change the way communities support people living with the disease?

References

1. https://www.apdaparkinson.org/living-with-parkinsons-disease/treatment-medication/
2. https://www.webmd.com/parkinsons-disease/drug-treatments
3. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01429-0/abstract
4. https://www.hopkinsmedicine.org/health/conditions-and-diseases/parkinsons-disease/parkinsons-treatment-options
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC6108190/
6. https://www.michaeljfox.org/medications-treatments
7. https://www.parkinson.org/living-with-parkinsons/treatment/exercise
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC11382789/
9. https://www.physio-pedia.com/Parkinson's_-_Physiotherapy_Management_and_Interventions
10. https://www.hopkinsmedicine.org/health/conditions-and-diseases/physical-therapy-for-parkinsons-disease
11. https://www.tandfonline.com/doi/full/10.1080/1028415X.2023.2233727
12. https://www.parkinson.org/living-with-parkinsons/management/diet-nutrition
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC9654624/
14. https://www.apdaparkinson.org/living-with-parkinsons-disease/mental-health/
15. https://practicalneurology.com/diseases-diagnoses/movement-disorders/mental-health-and-parkinsons-disease/30246/
16. https://www.ncoa.org/article/the-mental-health-aspects-of-parkinsons-how-its-more-than-a-movement-disease/
17. https://medschool.ucla.edu/news-article/holistic-approach-to-mental-health-care-for-people-with
18. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-21236-8
19. https://journals.sagepub.com/doi/10.1177/1877718X251330995